
Low penetrance sarcomere variants (LowSVs) contribute to mild HCM alone but increase severity with high-risk variants. @neallakdawala @drjamesware @tikuowens @jodieingles27 @S2beri @sday_hcm @SeanLZheng @AdamHelmsMD ahajournals.org/doi/abs/10.1…

Interested in inherited cardiomyopathies and understanding the basic mechanisms for disease.

Low penetrance sarcomere variants (LowSVs) contribute to mild HCM alone but increase severity with high-risk variants. @neallakdawala @drjamesware @tikuowens @jodieingles27 @S2beri @sday_hcm @SeanLZheng @AdamHelmsMD ahajournals.org/doi/abs/10.1…

The first set of #ESCGuidelines for cardiomyopathy. Fantastic to see standing room only at #ESCCongress2023 as guidelines aim to increase CM awareness outside the subspecialty #CardioGen clinic academic.oup.com/eurheartj/a…

Excited to share our work on iPSC-derived 2D cardiac muscle bundles. Accessible and reproducible contractile assessment, insights on cardiac development, disease modeling. Read @NatureComms rdcu.be/cz3pD @BakerLaboratory @LoriLIsom1 @yuweiwu_imb @umichCVC


Thread/ Check out our article on ACC.org @ACCinTouch discussing #mavacamten induced structural changes in #HCM - we also show example of #echofirst images over 144 weeks of treatment acc.org/latest-in-cardiology… Starting with the quick takes #cardiotwitter

Our paper on “The genetic architecture of Plakophilin 2 cardiomyopathy” is now online at @GIMJournal. Please check it out (and/or read the thread below) at rdcu.be/cmqCE ! 1/n

Excited to present our work on mortality after first infection in LVAD patients at virtual #ISHLT2021. Couldn't have done it without Guangyu Yang, @DLikosky @FPaganiMD, Carol Chenoweth, @PreetiNMalani @mdfetters @MichaelPienta, Lula Cabrera and the rest of the team!


Remote monitoring is the gold standard of care for patients with CIEDs, but current processes are laborious and error-prone. Check out our proposal to Transform Cardiac Device Care for the #FCVCInnovation Challenge! #EPeeps youtu.be/4DljYLChKAs @umichCVC @UMichCardiology

Check out our article on using micro-randomized trials (MRTs) for the evaluation of Just-in-Time Adaptive Interventions (JITAIs). Really excited to help others learn about this novel study design! ahajournals.org/doi/10.1161/… @CircOutcomes @bnallamo @Lisa_Jackson_MD

Look! Our paper on SuPAR predicting AKI in COVID-19 was voted the second biggest nephrology story by @NephJC! nephjc.com/news/2021/1/8/the… @salimhayek @CardiacLab

Excited to share our review in @Heart_BMJ discussing Multimodality Cardiovascular Imaging, strengths and limitations of different imaging modalities, and how it can be effectively delivered with @mdicarli and @RonBlankstein @BWHCVImaging heart.bmj.com/content/early/…

Check out this interesting case hosted by @CardioNerds and presented by @UMichCardiology Fellows Apu Chakrabarti, @JessicaGuidiMD, and @A__Deshmukh! With teaching points and insights by @D_Sukul and @KEagleMD! 〽️ #GoBlue
🎤71 is a must listen for every #CardioNerd🎆 https://t.co/iNpjmAFnHc A pt with Post-MI #VSR🚨 beats the odds🎲 w/ the help of @UMichCardiology greats -Apu Chakrabartim Jessica Guidi, & Amrish Deshmukh‼️ Priceless insights @keaglemd & @d_sukul 🙏 @EuniceDuganMD @karanpdesai

Our new study using #ISIC on #SuPAR and incidence of COVID19 related #AKI - new potential use for #SuPAR in risk stratification in COVID19 @salimhayek @UMichCardiology @umichCVC jasn.asnjournals.org/content…

**VALVE CASE OF THE WEEK** OK, this starts off about valves...but then isn't really about valves...but it's the broader educational point (which is relevant to valves) that I want to make this week...no poll I'm afraid, but as always, comments encouraged! 😁 @BrHeartValveSoc

Intronic #CRISPR Repair in a Preclinical Model of #Noonan Syndrome-Associated Cardiomyopathy. Learn more: ow.ly/71Zl50Brcnf #AHAJournals @moenklein @CyganekLukas @uniGoettingen @dzhk_germany